All-Cause Mortality and Bleeding Risks Associated With Serotonin Reuptake Inhibitors in Patients With End-Stage Kidney Disease and Depression: A Nationwide Cohort Study
In patients with ESKD and depression, the use of strong SRIs was associated with a reduced risk of all-cause death and major bleeding hospitalization compared to the use of weak or intermediate SRIs.
Authors
- Sojeong Park (ORCID: https://orcid.org/0000-0001-6019-6912)
- Yun Seob Jung (ORCID: https://orcid.org/0000-0002-5760-4054)
- Minae Park (ORCID: https://orcid.org/0000-0003-3703-4514)
- Byoung Geun Han (ORCID: https://orcid.org/0000-0002-3246-2993)
- Se‐Jeong Park
- Keunryul Park (ORCID: https://orcid.org/0000-0002-0749-6462)
- Jun Young Lee (ORCID: https://orcid.org/0000-0001-8047-4190)
- Jinhee Lee (ORCID: https://orcid.org/0000-0003-4255-1831)
- Dong Hui Shin (ORCID: https://orcid.org/0009-0006-2120-3263)
- Curmairah Keisha Cambridge (ORCID: https://orcid.org/0000-0001-6139-2915)
Institutions
- Yonsei University (KR)
- Hanmi Pharmaceutical (South Korea) (KR)
Publication Details
- Journal
- Psychiatry Investigation
- Published
- 2025-10-02
- DOI
- https://doi.org/10.30773/pi.2024.0359
- Primary Topic
- Electroconvulsive Therapy Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Korea Health Industry Development Institute
- Ministry of Science and ICT, South Korea